首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   7444篇
  免费   553篇
  国内免费   298篇
耳鼻咽喉   36篇
儿科学   96篇
妇产科学   133篇
基础医学   528篇
口腔科学   227篇
临床医学   718篇
内科学   1444篇
皮肤病学   71篇
神经病学   356篇
特种医学   236篇
外国民族医学   2篇
外科学   582篇
综合类   984篇
一般理论   3篇
预防医学   1654篇
眼科学   110篇
药学   409篇
  11篇
中国医学   250篇
肿瘤学   445篇
  2024年   13篇
  2023年   146篇
  2022年   225篇
  2021年   388篇
  2020年   448篇
  2019年   994篇
  2018年   716篇
  2017年   470篇
  2016年   234篇
  2015年   310篇
  2014年   438篇
  2013年   606篇
  2012年   350篇
  2011年   413篇
  2010年   308篇
  2009年   371篇
  2008年   282篇
  2007年   224篇
  2006年   209篇
  2005年   159篇
  2004年   120篇
  2003年   110篇
  2002年   85篇
  2001年   73篇
  2000年   72篇
  1999年   68篇
  1998年   31篇
  1997年   26篇
  1996年   49篇
  1995年   86篇
  1994年   64篇
  1993年   22篇
  1992年   14篇
  1991年   16篇
  1990年   12篇
  1989年   15篇
  1988年   24篇
  1987年   16篇
  1986年   10篇
  1985年   23篇
  1984年   16篇
  1983年   13篇
  1982年   8篇
  1981年   9篇
  1980年   5篇
  1978年   1篇
  1974年   2篇
  1973年   1篇
排序方式: 共有8295条查询结果,搜索用时 15 毫秒
1.
【目的】 通过比较2019年获得“中国科技期刊卓越行动计划”领军期刊项目资助的期刊(以下简称“领军期刊”)与其对标期刊,探索我国科技期刊缩小与世界顶级期刊差距的对策,为我国一流科技期刊建设提供参考和借鉴。【方法】 利用Web of Science (WoS) 数据库和期刊官网,检索并总结领军期刊与其对标期刊的各项指标数据,分析领军期刊最近5年来的发展情况。【结果】 22种领军期刊的主要指标数据明显上升。2020年领军期刊共发表Article 和Review文章4025篇,比2019年的2630篇增长53.0%,2020年刊均载文量为183篇,比2019年的120篇增长53.0%;领军期刊总被引频次由2019年的99767 次大幅增长至2020年的153610次,增幅达54.0%;2020年领军期刊的平均被引半衰期为3.73年,而对标期刊的平均被引半衰期为9.35年。2020年,16种领军期刊跻身JCR学科排名前10%,10种领军期刊跻身JCR学科排名前5%。【结论】 领军期刊应构建良性的期刊发展生态、动态调整期刊的发展目标、紧扣国家战略和重大需求布局期刊发展方向、重视人才发展与储备、构建自主可控的国际传播平台与渠道,以完成引领行业发展的使命任务,实现可持续发展,从而带动我国期刊行业的整体发展与进步。  相似文献   
2.
3.
自发性脑出血病死率和病残率较高,但缺乏有效的治疗策略。我国的脑出血相关研究与国际先进水平存在一定差距。近年国际上一系列临床研究从不同角度探讨脑出血的治疗方式,对我国脑出血研究和规范化治疗具有十分重要的参考价值。我国的脑出血临床治疗经验和研究成果要想走向世界,必须开展高质量的临床试验。四川大学华西医院神经外科正在开展INTERACT3试验,以及准备开展STICHⅢ试验,希望能够推动中国脑出血研究事业的进步。  相似文献   
4.
5.
6.
In low and middle-income countries mammographic breast cancer screening is prohibitively expensive and a cheaper alternative option is to use ultrasound as the primary screening test. In 2009, China launched a breast cancer screening programme for rural women aged 35–64 years with clinical breast examination coupled with ultrasound as the primary tool. Our study aimed to analyse the cost-effectiveness of breast screening compared to no screening among Chinese rural women. We developed a Markov model to estimate the lifetime costs and effects for rural women aged 35 years from a societal perspective. Asymptomatic women in the intervention arm were screened every 3 years before age 64 years. Breast cancer in the non-screening arm can only be diagnosed on presentation of symptoms. Parameter uncertainty was explored using one-way and probabilistic sensitivity analyses. Compared to no screening, breast cancer screening cost $186.7 more and led to a loss of 0.20 quality-adjusted life years (QALYs). Breast screening was more expensive and did harm to health among rural women with an incremental cost-effectiveness ratio (ICER) of $-916/QALY. The sensitivity analysis identified utility loss from false positives as the factor that most influenced the results, but this did not affect the conclusions. In a rural setting with such low breast cancer incidence, screening for asymptomatic disease is not cost-effective with current screening tools. Priority should be given to ensure that symptomatic women have proper access to diagnosis and treatment at an early stage as this will lead to mortality reductions without the usual screening harms.  相似文献   
7.
8.
AimsThis retrospective study aims to analyze and explore the clinical characteristics, risk factors, and in-hospital outcomes - including return of spontaneous circulation (ROSC) and survival to discharge - of hospitalized patients admitted with acute coronary syndrome (ACS) suffering cardiac arrest.MethodsACS patients admitted to three tertiary hospitals in Fujian, China, were evaluated retrospectively from January 1, 2012 to December 30, 2016. Data were collected, based on the Utstein Style, for all cases of attempted resuscitation for IHCA. We analyzed patient characteristics, pre-event variables, event variables, and the main outcomes, including ROSC and survival to discharge, and identified the influencing factors on the outcomes.ResultsThe total number of ACS admissions across the three hospitals during this study period was 21,337. Among these admissions, 320 ACS patients experienced IHCA (incidence: 1.50%); 134 (41.9%) patients experienced ROSC; and 68 (21.2%) survived to discharge. The findings indicated that four factors were associated with ROSC, including age <70 years-old, shockable rhythm, duration of resuscitation (≤15 min and 16–30 min), and PCI. Five factors were associated with survival to discharge, including age <70 years-old, shockable rhythm, the duration of resuscitation (≤15 min and 16–30 min), Killip ≤ II, and CCI ≤ 2.ConclusionYounger age, shockable rhythm, and shorter duration of resuscitation were all factors demonstrated to be a predictor of ROSC and survival to hospital discharge.  相似文献   
9.
10.
PurposeWe previously demonstrated that the functional inactivation of DAL-1 and TOB1 promotes an aggressive phenotype in gastric cancer cells, but the links between both genes and the survival of patients with gastric cancer are unknown. Here, we investigated the correlations of the expression levels of DAL-1 and TOB1 with the progression of gastric cancer.MethodsA total of 270 patients who underwent resectable gastrectomy were included. The expression of DAL-1 and TOB1 was detected by immunohistochemistry.ResultsLow expression of DAL-1 in cancer tissue was significantly associated with tumor site (p < 0.05), histological grade (p < 0.01), depth of invasion (p < 0.05), lymph node metastasis status (p < 0.05), Lauren classification (p < 0.001), and clinical stage (p < 0.01). A lower level of TOB1 was observed in gastric cancer patients with diffuse type disease compared to patients with either intestinal or mixed type disease (p < 0.001). Additionally, Spearman’s correlation analysis revealed that decreased expression of DAL-1 was positively correlated with low TOB1 expression (r=0.304, p < 0.001). The survival analysis showed that low levels of DAL-1 and TOB1 were significantly associated with poor survival of gastric cancer patients (p <0.001 and p < 0.05, respectively).ConclusionThe downregulation of DAL-1 and TOB1 expression is associated with shorter survival of gastric cancer patients. Hence, DAL-1 and TOB1 may be considered potential novel markers for predicting the outcomes of patients with gastric cancer.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号